Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhangzhou Pientzehuang Pharmaceutical., Ltd
  6. Summary
    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
424 438.93 437.95 433.9 434.99 Last
6922541 6521833 3875032 3061873 3013963 Volume
+0.33% +3.52% -0.22% -0.92% +0.25% Change
Estimated financial data (e)
Sales 2021 7 854 M 1 229 M 1 229 M
Net income 2021 2 516 M 394 M 394 M
Net cash position 2021 6 381 M 998 M 998 M
P/E ratio 2021 104x
Yield 2021 0,30%
Sales 2022 9 525 M 1 490 M 1 490 M
Net income 2022 3 126 M 489 M 489 M
Net cash position 2022 7 177 M 1 123 M 1 123 M
P/E ratio 2022 86,6x
Yield 2022 0,39%
Capitalization 262 B 41 049 M 41 062 M
EV / Sales 2021 32,6x
EV / Sales 2022 26,8x
Nbr of Employees 2 526
Free-Float 37,1%
More Financials
Company
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL.LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension, bupleurum granules for cold, as well as pharmaceuticals for bone injuries and others.... 
Sector
Pharmaceuticals
Calendar
04/11Earnings Release
More about the company
Ratings of Zhangzhou Pientzehuang Pharmaceutical., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
10/15Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
07/20MARKET CHATTER : Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth
MT
07/16Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
04/23Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar..
CI
01/27EXCLUSIVE : Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TC..
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
2020China stocks end lower as high-flying consumer shares retreat
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Est..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd agreed to acquire 29.2% stake in Longhui Ph..
CI
2020Longhui Pharmaceutical Co., Ltd. announced that it expects to receive CNY 44.4759 milli..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Announces Cash Dividend Per A Share for the..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year ..
CI
2019Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
More news
News in other languages on ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
2020Borsa Shanghai in calo, pesano titoli legati al consumo
More news
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration : Period :
Zhangzhou Pientzehuang Pharmaceutical., Ltd Technical Analysis Chart | 600436 | CNE000001F21 | MarketScreener
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 434,99 CNY
Average target price 468,56 CNY
Spread / Average Target 7,72%
EPS Revisions
Managers and Directors
Dong Ming Hong Chairman-Supervisory Board
Jie Pan Chairman
Fei Hong Chief Engineer
Jian Jun Jia Independent Director
Guang Pei Li Independent Director
Sector and Competitors